Principal Securities’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1
Closed -$32 3902
2025
Q1
$32 Hold
1
﹤0.01% 3540
2024
Q4
$32 Sell
1
-288
-100% -$13.7K ﹤0.01% 3535
2024
Q3
$16.7K Buy
289
+55
+24% +$2.7K ﹤0.01% 2211
2024
Q2
$9.49K Buy
234
+52
+29% +$2.06K ﹤0.01% 2418
2024
Q1
$7.64K Buy
182
+67
+58% +$2.61K ﹤0.01% 2460
2023
Q4
$4.41K Buy
+115
New +$3.83K ﹤0.01% 2572

Other funds holding ASTH

Principal Securities's ASTH Position: Q2 2025 in Review

Principal Securities sold out of Astrana Health (ASTH) in Q2 2025, closing a stake of 1 share — an estimated $32 sold.

Principal Securities first reported a position in ASTH in Q4 2023 and held it in 6 quarters. The position peaked at $16.7K in Q3 2024. 162 funds tracked by Wall St. Rank hold ASTH as of Q2 2025.

  • Principal Securities reported no remaining Astrana Health position as of Q2 2025 after selling out during the quarter.
  • Principal Securities sold 1 Astrana Health share in Q2 2025, an estimated $32.
  • Principal Securities first reported a position in Astrana Health in Q4 2023 and held it in 6 quarters.
  • Principal Securities's Astrana Health position peaked at $16.7K in Q3 2024.
  • 162 funds tracked by Wall St. Rank held Astrana Health as of Q2 2025.

Based on Principal Securities's 13F filing for Q2 2025, filed 11 Aug 2025.